Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $15.99, or
get to whole website for at least 3 months from $49.99.
Statement of Comprehensive Income
Difficulty: Beginner
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Bristol-Myers Squibb Co., Consolidated Statement of Comprehensive Income
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net earnings | |
|
|
|
|
||||||
| Derivatives qualifying as cash flow hedges | |
|
|
|
|
||||||
| Pension and postretirement benefits | |
|
|
|
|
||||||
| Available-for-sale securities | |
|
|
|
|
||||||
| Foreign currency translation | |
|
|
|
|
||||||
| Other comprehensive income (loss) | |
|
|
|
|
||||||
| Comprehensive income | |
|
|
|
|
||||||
| Comprehensive income (loss) attributable to noncontrolling interest | |
|
|
|
|
||||||
| Comprehensive income attributable to BMS | |
|
|
|
|
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
| Item | Description | The company |
|---|---|---|
| Net earnings attributable to BMS | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Bristol-Myers Squibb Co.'s net earnings attributable to BMS increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
| Comprehensive income attributable to BMS | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | Bristol-Myers Squibb Co.'s comprehensive income attributable to BMS increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
